screenshot pendingBlank Bio is a startup focused on precision oncology through the use of RNA intelligence. The company develops AI foundation models designed to assist pharmaceutical teams in identifying the appropriate patients for clinical trials and predicting disease progression. By leveraging the growing adoption of bulk RNA sequencing in clinical care and drug development, Blank Bio aims to transform how clinical trial decisions are made, moving beyond traditional biomarkers to utilize a more comprehensive understanding of each patient's underlying biology.
The core functionality of Blank Bio's offering…